Global Image-Guided Biopsy Market, By Technology (X- Ray, Ultrasound, Mammograpy, CT, MRI), Process (Fine Needle, Core Needle, Vacuum- Assisted Biopsy), End-User (Hospitals, Ambulatory Surgery Centers, Clinics, Research and Academic Institutes), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Image-Guided Biopsy Market
The image-guided biopsy market is expected to witness market growth at a rate of 5.49% in the forecast period of 2021 to 2028 and is expected to reach USD 3,063.03 million by 2028. Data Bridge Market Research report on image-guided biopsy market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The increase in the prevalence of cancer globally is escalating the growth of image-guided biopsy market.
Image- guided biopsy makes the use of imaging technologies in order to analyze the inside of the body. They utilized MIR, CT, ultrasound and x-ray for this procedure. The biopsy assists the medical professional to get the sample of the suspicious cell easily through the insertion of the needle into the best position. It is considered one of the best ways to collect samples as it causes no unnecessary injuries.
The rise in the incidences of chronic disease such as cancer among population across the globe acts as one of the major factors driving the growth of image-guided biopsy market. The initiatives taken by the government and global health organizations in raising the awareness regarding the disease and increase in research and development activities to enhance the treatment facilities accelerate the image-guided biopsy market growth. The increase in the inclination towards minimally invasive procedures owning to various features such as low risk of injuries and growth in awareness regarding the benefits of early diagnosis further influences the image-guided biopsy market. Additionally, aging population, public awareness about diseases and treatment options, improving healthcare infrastructure, increasing investment and surge in healthcare expenditure positively affect the image-guided biopsy market. Furthermore, technological advancements and innovations extend profitable opportunities to the image-guided biopsy market players in the forecast period of 2021 to 2028.
On the other hand, the rise in concerns related to risk of infections associated with the use of aspiration and biopsy needles is expected to obstruct the image-guided biopsy market growth. Underdeveloped healthcare infrastructure and dearth of well-trained radiologists and oncologists are projected to challenge the image-guided biopsy market in the forecast period of 2021-2028.
This image-guided biopsy market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on image-guided biopsy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Image-Guided Biopsy Therapy Market Scope and Market Size
The image-guided biopsy market is segmented on the basis of technology, process and end- user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of technology, the image-guided biopsy market is segmented into x- ray, ultrasound, mammograpy, CT and MRI.
- On the basis of process, the image-guided biopsy market is segmented into fine needle, core needle and vacuum- assisted biopsy.
- On the basis of end- user, the image-guided biopsy market is segmented into hospitals, ambulatory surgery centers, clinics and research and academic institutes.
Global Image-Guided Biopsy Therapy Market Country Level Analysis
The image-guided biopsy market is analyzed and market size insights and trends are provided by country, technology, process and end-user as referenced above.
The countries covered in the global image-guided biopsy market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the image-guided biopsy market because of the increasing prevalence of cancer in the U.S. and Canada and initiatives undertaken by local governments and global health organizations to raise the awareness regarding cancer in the region.
The country section of the image-guided biopsy market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The image-guided biopsy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for image-guided biopsy market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the image-guided biopsy market. The data is available for historic period 2011-2019.
Competitive Landscape and Image-Guided Biopsy Market Share Analysis
The image-guided biopsy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to image-guided biopsy market.
The major players covered in the image-guided biopsy market report are Koninklijke Philips N.V., Siemens Healthcare GmbH, Analogic Corporation, GENERAL ELECTRIC, Varian Medical Systems, Inc., Brainlab, Medtronic, Olympus Corporation, KARL STORZ Endoscopy India Pvt. Ltd., Stryker, Hologic, Inc. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-